Association between diabetes, obesity, aging, and cancer: Review of recent literature
Patients may benefit from evaluation if they have obesity, have overweight with related medical conditions, have struggled with weight loss despite lifestyle changes, or want medically supervised treatment options
GLP-1 solutions Other Weight Loss Medication GLP-1 Solutions Other Weight Loss Medication
Frequently Asked Questions In Phase 3 trials, retatrutide achieved 28.328.7% average weight loss versus tirzepatide's 22.5% a meaningful 56 percentage point difference
Before starting this medicine, it's important to discuss your current health status and any medicines you're taking with your doctor
Important considerations include existing medical conditions and current medications